메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Han Sang-Uk (Department of Surgery Ajou University School of Medicine 206 Worldcup-ro Yeongtong-gu Suwon 16502 Korea) Sang-Yong Son (Department of Surgery Ajou University School of Medicine Suwon Korea.)
저널정보
대한위암학회 Journal of Gastric Cancer Journal of Gastric Cancer 제23권 제1호
발행연도
2023.1
수록면
1 - 2 (2page)
DOI
10.5230/jgc.2023.23.e8

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
What is learned rapidly becomes outdated. Experiences and things learned by reading research evidence may be selective or inappropriately implemented. In addition, research evidence is everchanging and, consequently, no practitioner can keep abreast of all updates. However, quality and efficiency must be ensured to treat patients encountered in clinical practice. This may be the main reason why so much time is spent developing and reading guidelines. A clinical guideline is a systematically developed series of recommendations designed to assist decisions about appropriate health care in specific clinical circumstances. Guidelines should be based on evidence, but interpretation and implementation of that evidence require appreciation of its potential limitations [1, 2]. Although the Korean Gastric Cancer Association (KGCA) has developed and published the first and second editions of gastric cancer treatment guidelines since 2004, they were not widely used due to inconsistencies in medical reality. However, the third edition of the guidelines published in 2018, which provides a comprehensive description and statements for key questions (KQs), was rapidly and widely applied in practice after publication [3]. This issue of Journal of Gastric Cancer welcomes the publication of new Korean Practice Guidelines for Gastric Cancer [4]. This fourth edition of the guidelines was developed by specially assembled, multidisciplinary groups of experts including surgeons, gastroenterologists, oncologists, radiologists, and pathologists, assisted by the National Evidence-based Healthcare Collaborating Agency. The aim was to produce up-to-date, relevant, and practical recommendations using new scientific evidence that emerged after publication of the previous edition. There are 4 key points to consider when reading the new guidelines. First, the methodology used to draw conclusions about KQs was changed from a literature review to a systematic review. The level of evidence was also redefined based on the Grading of Recommendations, Assessment, Development, and Evaluation system, which is a de facto standard for high-quality systematic reviews and an essential component of trustworthy guidelines [5]. Second, the results of numerous Korean clinical studies such as SENORITA, PEGASUS-D, and PRODIGY as well as KLASS01–05 were used for the meta-analyses in these guidelines. It is very meaningful that the results of our research were used as a scientific basis for many KQs because this means that not only were our efforts worthwhile, but also that our international status in the academic society has risen further. Third, the emerging trend of anticancer treatments, such as in neoadjuvant chemotherapy, intraperitoneal chemotherapy, and palliative first-line nivolumab/second-line ramucirumab/third-line chemotherapy, was reflected in the new guidelines as much as possible. Lastly, considering that the number of gastric cancer survivors is growing due to early detection and improvements in therapeutics, surveillance for recurrence or nutritional assessment has been newly suggested [6]. However, this was based on a nationwide survey of each institution, not a clinical trial. Therefore, much remains to be done with regard to this issue in the next version of the guidelines. Gastric cancer remains one of the most common causes of cancer death in Korea and worldwide. A wide spectrum of treatment modalities has been developed and applied to treat gastric cancer over the past decades: surgery, endoscopic treatment, systemic chemotherapy, immunotherapy, targeted therapy, and radiotherapy all have proven efficacy in gastric adenocarcinoma. Therefore, a multidisciplinary approach is now paramount for treatment selection. In this respect, it is encouraging that a multidisciplinary team worked together to generate the new guidelines. It is also heartening that the KGCA played a valuable role for its members with the publication of the new guidelines and has plans to continue playing such a role. When we do our best to create and publish guidelines, it is our patients who truly benefit.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0